Galapagos NV
GLPG
#4552
Rank
โ‚น193.18 B
Marketcap
โ‚น2,932
Share price
-0.69%
Change (1 day)
29.64%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2025 (TTM): -โ‚น34.67

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is -โ‚น31.35. In 2024 the company made an earnings per share (EPS) of โ‚น107.75 a decrease over its 2023 EPS that were of โ‚น328.06.

EPS history for Galapagos NV from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น34.67-132.18%
2024โ‚น107.75-67.16%
2023โ‚น328.06-199.64%
2022-โ‚น329.2499.03%
2021-โ‚น165.43-68.98%
2020-โ‚น533.31-298.06%
2019โ‚น269.27-554.64%
2018-โ‚น59.23-77.18%
2017-โ‚น259.57-326.21%
2016โ‚น114.75-134.19%
2015-โ‚น335.60-371.34%
2014โ‚น123.68-445.98%
2013-โ‚น35.7532.88%
2012-โ‚น26.90-82.07%
2011-โ‚น150.08-817.9%
2010โ‚น20.9012.73%
2009โ‚น18.54-120.79%
2008-โ‚น89.18-37.67%
2007-โ‚น143.0939.64%
2006-โ‚น102.4728.17%
2005-โ‚น79.956.25%
2004-โ‚น75.25

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น1,030-3,384.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น346.59-1,205.50%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚น221.12-805.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น190.92-708.98%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
โ‚น675.51-2,254.65%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น494.61-1,677.63%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น348.35-1,211.13%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
-โ‚น56.39 79.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น114.64-465.66%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel